British pharmaceutical giant GlaxoSmithklineBeecham (GSK), manufacturer of the anti-herpes drug Valtrex ®, was recently investigated in respect of its anti-diabetes drug, Avandia. This drug has been known to increase the risk of heart attack [...]
|
|||||
|
A study reinforces the difficulties in formulating a successful vaccine against CMV, but on a positive note, if CMV could be used as a viral vector in the development of vaccine against HIV, Herpes, Hepatitis C and other viruses affecting the immune system, then unlike other viral vectors which may be used only once (due to their detection and future elimination by killer T cells). CMV could be used repeatedly to stimulate an immune response. [...] Emory Institute of Drug Discovery has teamed up with biotechnology company Zirus Inc. in an effort to produce up-to-the-minute anti viral drugs to combat such diseases as HIV, Herpes and even the common cold virus. [...] By extracting and treating stem cells, the antiviral DNA can theoretically be delivered directly to the patient’s auto-immune system, bypassing drug administration. Cells would be taken from the patient’s bone marrow, and treated with anti-viral DNA in vitro, after which the stem cells would be re-injected into the patient. [...] Fast Results!™ is approved under the FDA OTC Antiseptic/Antimicrobial Monograph. It combines Viracea already used in Releev along with a new patented technology. Its main goal is to alleviate the pain and discomfort associated with genital herpes outbreaks. The product will be available in CVS stores from mid May and from Rite Aid stores shortly afterwards. There is currently no news on its future availability outside the United States. [...] Preliminary test results from Paris-based BioAlliance Pharma group show their antiviral acyclovir Lauriad® reduced the healing time for patients with facial herpes lesions, as well as preventing the onset of lesions in some patients who presented prodromal symptoms (e.g. initial tingling). [...] |
|
||||
|
Copyright © 2012 Herpes News - All Rights Reserved Bad Behavior has blocked 39 access attempts in the last 7 days. |
|||||
